3.4 Calcium Antagonists * Nifedipine SR ADALAT-CC * Verapamil CALAN * Verapamil SR CALAN SR * * Diltiazem & Diltiazem DILACOR XR, CARDIZEM, ER CARDIZEM-SR, TIAZAC * Isradipine DYNACIRC, DYNACIRC CR * Felodipine PLENDIL Nifedipine PROCARDIA * CALAN SR is the only BRAND-NAME Verapamil covered 3.5 Antidysrhythmic Drugs Avoid combining agents of the same class or agents with potentially additive side effects QT interval prolongation, negative inotropic effects, etc. ; Antiarrhythmics may provoke arrhythmia proarrhythmia hypokalemia enhances the proarrhythmic effect of many drugs. The risk of proarrhythmia increases with worsening left ventricular function and ischemia * Amiodarone CORDARONE, PACERON * Procainamide SR PROCANBID * Procainamide PRONESTYL * Quinidine gluconate QUINAGLUTE Quinidine sulfate SR QUINIDEX * Quinidine Sulfate QUINIDINE SULFATE 3.6 Angiotensin Converting Enzyme Inhibitor ACE inhibitors may precipitate acute renal failure and hyperkalemia in patients with severe heart failure, pre-existing renal disease, or hypovolemic states Use of ACE inhibitors in the second and third trimesters of pregnancy can harm or even kill a developing fetus and are contraindicated in pregnancy Co-administration of ACE inhibitors with potassium or potassium -sparing diuretics increases the risk of hyperkalemia. * Quinapril ACCUPRIL and zestril.
Computed tomography scanning provides an excellent tool for evaluation of sinus disease, particularly in cases of chronic rhinosinusitis. The CT can demonstrate disease that is not shown on routine X-rays. While CT scanning may demonstrate disease not shown on plain radiographs, the scan may not reveal the extent of disease actually present. CT scans are not necessary for the management of children with uncomplicated acute bacterial rhinosinusitis. Indications for CT scan include pre-operative workup and in cases where suppurative or impending suppurative complications are suspected. Confirmation of the diagnosis of rhinosinusitis can be made by culturing an aspirate of the sinus secretions. While not completely free of morbidity as these children typically require a general anesthesia, a properly performed sinus aspiration allows for precise identification of the offending pathogen as well as the sensitivities of the organism to appropriate antibiotics. Indications for sinus aspiration in children include severe toxic illness, acute illness unresponsive to antibiotics within 72 hours, immunocompromised patients, suppurative complications, workup for fever of unknown origin . Unfortunately, nasal, oropharyngeal, and nasopharyngeal cultures correlate poorly with cultures of sinus aspirates. Therefore, it is not recommended to undertake these cultures as guides to the bacteriology and therapy of acute or chronic rhinosinusitis. Endoscopically guided culture of the middle meatus correlates well with maxillary or ethmoid sinus aspirates and is definitely less invasive than sinus puncture; this procedure requires a cooperative child. Random nasal swabs show little correlation with maxillary cultures.

A phase ii study of brivinib, a targeted cancer therapy that is administered orally at a dose of 800 mg daily in patients with inoperable, locally advanced, or metastatic liver cancer who have received one prior regimen of rntiangiogenesis therapy and trandate. A method and apparatus of providing an electronic-guide to television programming provides a headend database and processor which segments and categorizes programming information which is then broadcast in a hierarchy over an out-of-band channel. Individual subscriber's set-top terminals access and display the guide information direct from the headend server in response to input from the subscriber. Alternatively, 'individual set-top terminals submit requests for particular guide information which are filled by the server serially over the out-of-band channel. ABSTRACT #315 THE USE OF A QUESTIONNAIRE AND A VON WILLEBRAND FACTOR DIAGNOSTIC PROFILE TO EVALUATE RISK AND SIGNS OF HEMORRHAGE IN NORMAL DOGS AND DOGS WITH VON WILLEBRAND DISEASE. H.J. Burgess, J.P. Woods, A.C.G. Ogg, R.M. Jacobs, R.D. Wood. Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada. Commonly reported signs of bleeding in dogs with von Willebrand Disease vWD ; include epistaxis, hematuria, gastrointestinal hemorrhage, prolonged estral bleeding, gingival bleeding at tooth eruption, hematomas, ecchymoses and excessive hemorrhage after surgery or trauma. However, vWD positive animals do present without a significant bleeding history, and the vWF: Ag concentration does not accurately reflect hemorrhagic tendencies. Availability of a method to predict risk of hemorrhage in dogs with vWD would be beneficial in patient management. In human medicine, bleeding questionnaires are most frequently used to aid in strategic diagnostic testing of vWD. The objective of this study was to use a bleeding questionnaire i ; for characterization of hemorrhagic signs, ii ; to assess its value as a predictor of vWD status, and iii ; for evaluation of the vWD diagnostic profile platelet function analysis using the PFA-100, Collagen binding assay vWF: CBA ; , and von Willebrand factor vWF ; antigen ELISA ; as a predictor of hemorrhagic risk. vWF concentration and function was assessed in 165 canine blood samples using the vWD diagnostic profile. Hemorrhagic signs for each dog were obtained using a standardized questionnaire. Questionnaires were scored according to a previously prepared scoring key. Of the 165 dogs in the study, 43.6% were designated as vWD positive, with only 48.6% of this group reporting hemorrhagic signs. In the vWD positive group, excessive bleeding from minor wounds was the most commonly reported hemorrhagic In conclusion, Greyhounds administered morphine acepromazine before AlfaxanH experienced anaesthetic durations approximately 5 times longer than un-premedicated Greyhounds. In addition, the volume of distribution of the central compartment Vc ; in premedicated Greyhounds was less than when un-premedicated, which may partially explain why premedicated dogs require less anaesthetic. The pharmacokinetics of alfaxalone in greyhounds and beagles are similar and lasix.
The typical group insurance policy excludes drugs administered in hospitals, and insurers are refusing to pay these claims. the insurance industry's position is that billing patients for hospital-administered drugs is a violation of the Canada Health Act cHa ; . cancer care ontario which funds cancer drugs in ontario ; has a legal opinion that it is not violating the cHa by billing patients for these drugs. clearly, a consistent federal position and strategy is needed, but no clear answer is expected soon. While the issue of cancer drugs continues to be widely debated, some insurers are suggesting that all hospital drugs could eventually be billed to patients. it is prudent for employers to develop their own positions and to be conservative when considering the longterm impact of government policy changes on their benefits plans.
Psychiatry, Nottinghamshire Healthcare NHS Trust, Nottingham, Nottinghamshire, United Kingdom Background: The concept of patient centeredness within mental health has been incorporated into both UK and international governmental policy on mental health provision. Our group's research suggests most schizophrenia research is not patient centered. If patient centeredness is to be embraced it should be reflected in both the CONTENT and PROCESS of research. This abstract reflects on measures taken during the SONAR study to promote patient centeredness. The SONAR study: The Study Of Nottingham youth At Risk cleaves to the `high risk' paradigm employing clinical, neuropsychological and neurophysiological assessments EEG & fMRI ; to elucidate risk factors for adolescent onset schizophrenia. The study compares young people with a diagnosis of schizophrenia, their `high risk' siblings and healthy controls with the aim of and vasotec!

27 16. 16.1 ORDERS: AFTER considering submissions as to penalty the Tribunal orders: 16.1.1 16.1.2 16.1.3 THAT Dr Walkey by censured; THAT Dr Walkey pay a fine of , 000.00; THAT Dr Walkey contribute 40% of the costs and expenses of and incidental to the investigation made by the Health and Disability Commissioner, prosecution of the charge by the Director of Proceedings, and the hearing by the Tribunal. 16.1.4 THAT publication of the name, or any of the particulars of the affairs of Ms A prohibited; 16.1.5 THAT the order made in Decision No. 26 97 17D prohibiting publication of the name of Dr Walkey pending the outcome of the proceedings be discontinued. 16.1.6 THAT publication under Section 138 of the Act be made in the New Zealand Medical Journal and lisinopril. For most patients, start with 10 mg t i d, and titrate over 7 to 14 days, using the patient's blood pressure response, attack frequency, sublingual nitroglycenn intake and activity level as a guide Titration may be more rapid e.g, 3 days ; if symptoms warrant and the patient is observed closely. Because PROCARDIAdecreases peripheral vascular resistance occasional patients have had excessive hypotension ; , careful monitoring of blood pressure during initial administration and upward dosage titration is suggested, especially for patients taking other drugs known to lower blood pressure Occasional patients have developed increased frequency, duration or severity of angina on starting PROCARDIA or at the time of dosage increases. Damaging effects of a drug or drugs. Cells have several ways to develop drug resistance see Multidrug Resistance ; . Sanctuary Sites These are areas in which it is difficult to get a sufficient concentration of chemotherapy to destroy leukemia cells. In acute lymphocytic leukemia, the brain and spinal cord central nervous system ; and the testes in boys are sanctuary sites of cancer. Somatic Mutation This event is the alteration of a gene in the cells of a specific tissue causing the gene to become a cancer-causing gene or oncogene. It is called "somatic" to distinguish it from a germ cell mutation, which can be passed from parent to offspring. Most cases of leukemia are caused by a somatic mutation in a primitive marrow blood-forming ; cell. If the mutation results from a major abnormality of chromosomes such as a translocation, it can be detected by cytogenetic examination. Often the alteration in the gene is more subtle and requires more sensitive tests to identify the oncogene. Spleen An organ of the body in the left upper portion of the abdomen just under the left side of the diaphragm. It contains clusters of lymphocytes like lymph nodes do and also filters the blood of old or worn out blood cells. It is often affected in leukemia, especially the lymphocytic leukemias, and Hodgkin and non-Hodgkin lymphoma. Enlargement of the spleen is referred to as "splenomegaly." Removal of the spleen by surgery is referred to as "splenectomy." Removal of the spleen can be done since its function can be performed by other organs such as the lymph nodes and liver. Stem Cells These are primitive cells in marrow that are important in making red blood cells, white blood cells, and platelets see Hematopoiesis ; . Generally and vytorin. Topically for minor skin lesions, bruises and sprains 3, 5, 20 ; , local inflammation of the skin and mucous membranes 3, 5, 2024 ; , haemorrhoids 3, 5, 20, ; and varicose veins 3. The American Psychiatric Association invites applicationsforthe 1992 APA PIA Foundation Award for Research Development in Hospital Psychiatry. The APA PIA Foundation Development in Hospital two separate awards: 1 ; Award for Research Psychiatry consists of and zebeta.
Pediatric renal cell carcinoma: single institution 25 year case series and initial experience with partial nephrectomy cook a, lorenzo aj, salle jl, bakhshi m, cartwright lm, bagi d, farhat w, khoury a, division of urology and department of pathology, hospital for sick children and university of toronto, toronto, ontario, canada.

County Mental Health Depart Chico, CA ; is Accepting C.V.'s for Psychiatrist. This position would. Of phenothiazines, but less than that of certain aliphatic phenothiazines. Restlessness, agitation and insomnia have been noted with Navane thiothixene ; . Seizuresand paradoxi cal exacerbation of psychotic symptoms have occurred with Navaneinfrequently. Hyperreflexia has been reported in infants delivered from mothers having received structurally related drugs. In addition, phenothiazinederivativeshave been associated with cerebral edema and cerebrospinal fluidabnormalities. Extrapyramidal symptoms, such as pseudo-parkinsonism, akathisia, and dystonia have been reported. Management of these extrapyramidal symptoms depends upon the type and severity.Rapidreliefofacute symptomsmayrequirethe use of an injectableantiparkinson gent.Moreslowlyemergingsymp a toms may be managed by reducing the dosage of Navane and oradministeringan oral antiparkinson agent. Persistent Tardive Dyskinesia: As with all antipsychotic agents tardivedyskinesiamayappearin some patientson long term therapy or may occur after drug Iherapy has been discon tinued. The risk seems to be greater in elderly patients on high-dose therapy, tent and in some patientsappearto be irreversible. he syn T drome is characterized rhythmicalinvoluntarymovements by of the tongue, face, mouth orjaw e.g., protrusionof tongue, puffingofcheeks, puckeringof mouth.chewing movements ; . Sometimes these may be accompanied by involuntary move ments of extremities. Thereis no antiparkinsonism agents usuallydo not alleviate the symptoms ofthis syndrome. It issuggested thatallantipsychotic agents be discontinuedifihese symptomsappear. Should itbe necessary to reinstitute treatment.orincreasethe dosage ofthe agent, orswitch toa different antipsychoticagent, the syndrome may be masked. It has been reportedthat tine vermicularmovements of the tongue may be an early sign of the syndrome and if the medication is stopped at that time, the syndrome may not develop. Hepatic effects: Elevations of serum transaminase and alkaline phosphatase, usually transient, have been infre quently observed in some patients. No clinicallyconfirmed cases ofjaundice attributable to Navane have been reported. Hematologic effects: As is true with certain other psycho tropic drugs, leukopenia and leukocytosis. which are usually transient, can occur occasionally with Navane. Other antipsy chotic drugs have been associated with agranulocytosis, eosinophilia, hemolytic anemia, thrombocytopenia and pancy topenia. Allergicreactions: Rash, pruritus, urticaria, photosensitivity and rare cases ofanaphylaxis have been reported with Navane. Undue exposure to sunlight should be avoided. Although not experienced with Navane, exfoliative dermatitisand contact dermatitis in nursing personnel ; have been reportedwith certain phenothiazines. Endocrine disorders: Lactation, moderate breast enlarge ment and amenorrheahave occurredin a small percentageof females receiving Navane. If persistent. this may necessitate a reduction in dosage or the discontinuation of therapy. Phenothiazines have been associated with false positive preg nancy tests, gynecomastia, hypoglycemia, hyperglycemia, nd a glycosuria. Autonomic effects: Dry mouth, blurred vision, nasalconges tion, constipation, increasedsweating, increased salivation, and impotence have occurredinfrequentlywith Navane therapy. Phenothiazines have been associated with miosis, mydriasis, and adynamic less. Other adverse reactions: Hyperpyrexia, anorexia, nausea, vomiting, diarrhea, increaseinappetiteandweight, weaknessor fatigue, polydipsiaand peripheraledema. Although not reported with Navane, evidence indicates there is a relationshipbetween phenothiazinetherapyand the occurrence of a systemic lupus erythematosus-like syndrome. NOTE: Sudden deaths have occasionallybeen reportedin patients who have received certain phenothiazine derivatives. In some cases the causeofdeath was apparently cardiacarrest or asphyxiadue to failureof the cough reflex. In others, the cause could not be determined nor could it be es tablished thatdeath was dueto phenothiazine administration. Dosage and AdmInistration. Dosage of Navane should be individuallyadjusted depending on the chronicity and severity ofthe condition. In general, smalldosesshould be used initially and graduallyincreasedto theoptimaleffectivelcvel, basedon patientresponse. Some patients have been successfullymaintained on once-aday Navane therapy. Usage in children under 12years ofage is not recommended because safe conditions for its use have not been established. Myeloma Lymphoma. Appropriate if myeloma and or lymphoma are suspected often on the basis of an M-component in serum ; . Markers include: CD3, CD4, CD5, CD8, CD10, CD14, CD16 56, CD19, CD20, CD23, CD38, CD45, CD56, surface kappa and lambda for mature B cells, cytoplasmic kappa and lambda for plasma cells. If monoclonal B cells are identified then evaluation proceeds as indicated under Lymphoma Lymphocytosis. If a protocol that subdivides patients on the basis of DNA ploidy results is to be used for someone with myeloma or in those cases in which stem cell transplant therapy is contemplated, a DNA ploidy study may also be appropriate. It should be noted that flow cytometry is NOT a good quantitative technique in the differentiation between plasma cell dyscrasias eg, mgUS vs myeloma ; for a variety of reasons; estimates of the percent plasma cell involvement should be made by morphology from the bone marrow aspirate and or biopsy and not by flow cytometry techniques. CTCL. Appropriate when a clinical diagnosis of CTCL has been made and initial organ involvement is being determined. Markers include: CD2, CD3, CD4, CD5, CD7, CD8, CD14, CD16 56, CD19, CD25, CD45, CD45RA, CD45R0, kappa, lambda. Followup studies on a diagnosed patient should usually involve either a customized panel or the above markers without the kappa and lambda studies. Immunodeficiency. This is most appropriate for detailed evaluation of a non-HIV + immunodeficient patient. This is NOT appropriate for simple T&B cell subsets used to follow patients with HIV disease. When T&B cell subsets are ordered, only the numbers percent and absolute count ; are reported CD3 + , CD3 + CD4 + , CD3 + CD8 + , CD4 CD8 ratio calculated ; , CD16 56 + CD3-, and CD19 + ; . There is no routine morphologic review by the pathologist nor is an interpretive report issued. In the case of T&B subsets, the case will be reviewed by the pathologist if any unusual phenotype cells are identified by the standard immunophenotyping. For the extensive immunodeficiency evaluation panel, the markers included are: CD1, CD3, CD4, CD5, CD8, CD10, CD11b, CD16, CD18, CD19, CD23, CD43, CD45, CD45RA, CD45R0, CD62L, TcR delta, HLA ABC, kappa, lambda. A full interpretation accompanies such an extensive Immunodeficiency evaluation. For followup of these patients, the most appropriate is usually standard T&B cell subsets plus evaluation of any specific abnormalities identified in the initial evaluation. PNH. Markers include CD14, CD45, CD55, CD59. Flow cytometry is considered to be the most sensitive way to diagnose PNH. See also the section on pancytopenia below. BAL Analysis. If BAL analysis is undertaken to look for lymphoma or to assess for hypersensitivity and or granulomatous disease, then the markers include: CD3, CD4, CD8, CD16 56, CD19, CD45, kappa, lambda. If lymphoma is not in the differential diagnosis, then the kappa and lambda analysis is eliminated. Post Stem Cell Transplant. In blood, the usual most appropriate panel includes T cell subsets and an evaluation for monoclonal B cells especially in the case of HLA-mismatched allo transplants or T-cell depleted allo transplants in which the risk for development of post-transplant lymphoproliferative disease is high ; and rarely a 'customized' one for the patient's underlying disease, e.g. circulating blasts for leukemia. In marrow, the most appropriate panel is generally a 'customized' one for the patient's underlying disease. Pancytopenia Myelodysplasia Possible Lymphoproliferative Disease. For some bone marrow samples, the clinical history and the morphologic review leaves open a relatively wide differential diagnosis. In these cases, the most appropriate panel is often one that examines for the following markers: CD3, CD4, CD7, CD8, CD10, CD11b, CD16, CD19, CD13, CD33, CD34, CD45, CD57, CD64, CD71, CD117, glycophorin, kappa, lambda. This constitutes a reasonable screening procedure for myelodysplasia, lymphoma, and large granular lymphocytosis. Additional evaluation may be undertaken depending on those results. For a clear case of myelodysplasia on morphologic review where characterization of the blasts is critical, then an evaluation similar to "acute leukemia" is undertaken albeit carried out in a slightly different technical fashion in order to best define the relatively less frequent blast population ; . In suspected aplastic anemia, the first panel noted above is often most appropriate in order to rule out lymphoma, LGL disease and myelodysplasia - in that case, PNH evaluation may also be appropriate to add. Mastocytosis. Usually the most appropriate evaluation for suspected mastocytosis is to look for lymphoproliferative disease as outlined above and then to look for normal phenotype and abnormal phenotype mast cells by additional evaluation of: CD2, CD25, CD34, CD33, CD64, CD117. Eosinophilia. Patients with eosinophilia may have the disorder on the basis of abnormal clones of T cells producing appropriate cytokines. Usually, the most appropriate panel is: CD3, CD4, CD5, CD7, CD8, CD14, CD16 56, CD19, CD25, CD45, CD64, TcR delta. If other lymphoproliferative disease and or myeloproliferative disease is in the differential based on clinical history and morphologic review, then it may be appropriate to further modify this panel. He Court of Appeal of Louisiana recently ruled that a civil jury was wrong not to find the hospital's nurses negligent. The court overruled the jury and ordered a judgment to be entered against the hospital for the patient's death from a stroke. He was hospitalized for a bleeding duodenal ulcer and was getting blood products. He had a history of hypertension. Four months later, after hearing additional evidence, the court reversed itself. Careful review of the ICU brain scans showed the patient in fact died from a thrombotic stroke, not a hemo rrhagic stroke. A thrombotic stroke, the court reasoned, would not be caused or made more likely by the nurses' actions, whether or not the nurses' actions fell below the legal standard of care. The court dismissed the case. Physician's PRN Medication Order The orders included vital signs every four hours and Proardia PRN for blood pressure above 160 95. The nurses took his vitals at 4: 00 His blood pressure was 170 100 but they did not give the Procardia. The patient's vitals were taken again at 7: 30 p.m. His blood pressure was 173 100 and he got the Procardia. He became unresponsive at midnight. All the signs indicated a stroke. Thspe1ds es, OSITWlIKH# 6.dPlfC * U11OS6. %vdsmdis. e.gaeozien, n# oolan, hErotwn, &1 stuseM IIedeeIsZeSmeO&ZIfhy &rie.ihn. P * O * 0, oeozupwi Wenozepwn ; iS buatead hyfeeseurie. tMn wd * eOZObnOQtI, e lrieleredtasleodystats, ; MJ , mce.T ; okjn waodniioered done; aol cbawice * os re&ed hy drosS 5O' Theld phone phearolen canceneosisa reeSe ur lead edonatorpefw nene ad memory flal iOemctiw .lieoh ba rail. inuesolgomed seiw isa dhresceerie, ney he moe pronomnif a 300mg iph dose ia $e isce&mnaaleedSWrenalokaleShsoeele mogy 1tB3WTm Seazobon iaCOO&isiIsedM [IMiXTudeeta, Ire ii BrSegewonneotiaregiedboU1MtTobht p IecaoeBrvosenireslsces * isdozepam, there * 15Omg deydeaie s.oleh * edodejoed. Excretion Estradiol, estrone, and estriol are excreted in the urine along with glucuronide and sulfate conjugates. Special Populations No pharmacokinetic studies were conducted in special populations, including patients with renal or hepatic impairment. Drug Interactions In vitro and in vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 CYP3A4 ; . Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism. Inducers of CYP3A4 such as St. John's Wort preparations Hypericum perforatum ; , phenobarbital, carbamazepine, and rifampin may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and or changes in the uterine bleeding profile. Inhibitors of CYP3A4 such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice may increase plasma concentrations of estrogens and may result in side effects. OBJECTIVE: To analyze price and utilization trends for Calcium Channel Blockers CCB ; drugs, and to compare the price difference between brand-name and generic CCB drugs over a specific time interval. METHODS: CCB drugs with an indication for hypertension were selected for this study. The First DataBank drug files and National Medicaid Pharmacy data were used to calculate the monthly Average Wholesaler Prices AWP ; , quarterly prescription use and reimbursement. Descriptive time-series trend analyses were performed to assess price trends and drug utilization patterns. The market shares were calculated as the proportion of total number of prescriptions. RESULTS: The average AWP per daily dose for CCBs included three tiers: the highest with or more per day for Cardizem, Plendil, and Proca5dia XL, the lowest with or less per day for Isoptin and verapamil, and middle for Norvasc and Cardene. The generic dilatizem AWP decreased from ##TEXT##.84 in 1996 to ##TEXT##.34 in 2004, while its brand Cardizem AWP increased over time. Use of branded drugs Calan, Procardia, and Cardizem ; decreased while use of generics verapamil, nifedipine, and diltiazem ; increased. The utilization of the dihydropyridine CCBs e.g. Norvasc, Procardia ; was about two-fold that of the non-dihydropyridine CCBs in 2004. Total expenditure for brand name drugs increased from .87 million per quarter in 1991 to .15 billion per quarter in 2004. The market-share of. Directorship Position Near Ohio; An Hour from Charleston - Live Like a King Queen and Leave Big City Stresses Behind - Horizon Health has a wonderful inpatient opportunity for the psychiatrist who likes to be in something new. Offering outstanding salary with benefits or practice guarantee with administrative stipend. Sign-on bonus or Assistance with Student Loan repayment is an option. Outpatient work is optional. Live work in a beautiful, friendly, growing community with great schools, affordable housing and a low cost of living surrounded by a variety of recreational choices. The crime rate in WV is next to the lowest in the nation. Please call Terry B. Good, Horizon Health, at 1-866-865-7380, Fax #: 804-684-5663; email: terry.good horizonhealth . Or mail CV to: 1663 Denton Lane, Hayes, VA 23072.

A federal continuation of coverage law, known as the Consolidated Omnibus Budget Reconciliation Act of 1985 COBRA ; , as amended, may apply to your Group Health Plan. If COBRA applies, you or your Covered Dependents may be entitled to continue coverage for a limited period of time, if you meet the applicable requirements, make a timely election, and pay the proper amount required to maintain coverage. You must contact FCCRMC to determine if you or your Covered Dependent s ; are entitled to COBRA continuation of coverage. FCCRMC is solely responsible for meeting all of the obligations under COBRA, including the obligation to notify all Covered Persons of their rights under COBRA. If you fail to meet your obligations under COBRA and this Benefit Booklet, FCCRMC will not be liable for any claims incurred by you or your Covered Dependent s ; after termination of coverage. A summary of your COBRA rights and the general conditions for qualification for COBRA continuation coverage is provided below. The following is a summary of what you may elect, if COBRA applies to FCCRMC and you are eligible for such coverage: 1. You may elect to continue this coverage for a period not to exceed 18 months * in the case of: a ; termination of employment of the Covered Employee other than for gross misconduct; or b ; reduced hours of employment of the Covered Employee. * Note: You and or your Covered Dependent s ; are eligible for an 11 month extension of the 18 month COBRA continuation option above to a total of 29 months ; if you or your Covered Dependent s ; is are totally disabled as defined by the Social Security Administration SSA at the time of your termination, reduction in hours or within the first 60 days of COBRA continuation coverage. The Covered Person must supply notice of the disability determination to FCCRMC within 18 months of becoming eligible for continuation coverage and no later than 60 days after the SSA's determination date. 2. Your Covered Dependent s ; may elect to continue their coverage for a period not to exceed 36 months in the case of: a ; the Covered Employee's entitlement to Medicare; b ; divorce or legal separation of the Covered Employee; c ; death of the Covered Employee; d ; the employer files bankruptcy subject to Bankruptcy Court approval or e ; a dependent child may elect the 36month extension if the dependent child ceases to be an Eligible Dependent under the terms of FCCRMC's coverage. Children born to or placed for adoption with the Covered Employee during the continuation coverage periods noted above are also eligible for the remainder of the continuation period. Additional requirements applicable to continuation of coverage under COBRA are set forth below: 1. The Employer and or designated COBRA administrator must notify you of your continuation of coverage rights under COBRA within 14 days of the event which creates the continuation option. If coverage would be lost due to Medicare entitlement, divorce, legal separation or the failure of a. LIM ITATIONS 1. 2. J3490 may be used ONLY for new or unlisted drugs that do not have a specific code. J9999 may be used ONLY for an unlisted anti-neoplastic drug.

Procardia usage

Discount generic Procardia online

Cost of procardia, procardia xl dosage, procardia side, procardia for raynaud's and procardia usage. Discount generic procardia online, effects of procardia on fetus, will procardia hurt my baby and nifedipine procardia or procardia cream.

Effects of procardia on fetus